Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Fischer, DK
David Fischer, Stenlose DK
| Patent application number | Description | Published |
|---|---|---|
| 20100017006 | METHOD AND SYSTEM FOR CREATING NON-OCCLUDING EARPIECES - The present invention provides a method for computer-controlled creation of non-occluding earpieces with tube bore. The non-occluding earpieces are created based on a three-dimensional computer model of at least part of the outer ear and at least part of the auditory canal. The said model is created by a laser scanner, in the ear scanner or by other means. The said three-dimensional computer model is virtually modified to create the non-occluding earpieces and the tube bore. Finally the physical non-occluding earpieces are manufactured using rapid prototyping equipment. | 01-21-2010 |
Erik Fischer, Vaerlose DK
| Patent application number | Description | Published |
|---|---|---|
| 20100234473 | PROCESS FOR PREPARATION OF 3-(2-HYDROXY-5-SUBSTITUTED PHENYL)-N-ALKYL-3-PHENYLPROPYLAMINES - A new process for preparation of 3-(2-hydroxy-5-substituted phenyl)-N,alkyl-3-phenylpropylamines from cinnamyl chloride via N-alky-3-phenylprop-2-en-1-amine has been developed. | 09-16-2010 |
Gina Fischer, Vaerlose DK
| Patent application number | Description | Published |
|---|---|---|
| 20080234352 | Controlled release solid dispersions - A controlled release pharmaceutical composition for oral use comprising a solid dispersion of i) at least one therapeutically, prophylactically and/or diagnostically active substance, which at least partially is in an amorphous form, ii) a pharmaceutically acceptable polymer that has plasticizing properties, and iii) optionally a stabilizing agent, the at least one active substance having a limited water solubility, and the composition being designed to release the active substance with a substantially zero order release. The polymer is typically a poly ethylene glycol and/or polyethylene oxide having a molecular weight of at least about 20,000 in crystalline and/or amorphous form or a mixture of such polymers, and the active substance is typically carvedilol. The composition may comprise a coated matrix, the coating comprising a first cellulose derivative which is substantially insoluble in the aqueous medium, and at least one of a) a second cellulose derivative which is soluble or dispersible in water, b) a plasticizer, and c) a filler. | 09-25-2008 |
| 20080254122 | Polymer release system - A pharmaceutical composition for controlled release of an active substance, the composition being a matrix composition of: (a) a substantially water soluble or crystalline polymer, (b) an active substance, and optionally, (c) one or more pharmaceutically acceptable excipients having a water solubility of at least 1 mg/ml at ambient temperature. The matrix composition does not contain a water dispersible or water soluble surface active agent that has at least one domain, which is compatible with the polymer in the matrix composition, and which substantially eliminates water diffusion between the interface between the polymer crystals. | 10-16-2008 |
| 20080254123 | Morphine polymer release system - A pharmaceutical composition for controlled release of an active substance is provided. The active substance is released into an aqueous medium by erosion of at least one surface of the composition. The composition comprises i) a matrix comprising a) polymer or a mixture of polymers, b) an active substance and, optionally, c) one or more pharmaceutically acceptable excipients, and ii) a coating. | 10-16-2008 |
| 20080268057 | Controlled release carvedilol compositions - A controlled release pharmaceutical composition for oral use comprising carvedilol. The composition releases carvedilol after oral administration to a mammal, including a human, in such a manner that a prolonged residence of carvedilol is obtained in the circulatory system compared with the known compositions of carvedilol. Furthermore, a composition according to the present invention makes available to the body a suitable plasma concentration of one or both of the enantiomeric species, namely R(+) and/or S(−) carvedilol for obtaining the desired therapeutic effect. | 10-30-2008 |
| 20080299199 | Swellable Dosage Form Comprising Gellan Gum - A novel dosage form. The dosage form is presented in particulate form and before oral ingestion the particulate material is subjected to an aqueous medium, whereby it is converted to a semi-solid form by swelling or gelling of one or more of the components, especially of a gellan gum, of the particulate matter. The invention also relates to a vehicle for oral administration of one or more active substances, the vehicle comprising a gellan gum arranged in a configuration allowing optimal water diffusion so that upon addition of a predetermined amount of an aqueous medium, without the necessity of applying shear forces or other mixing forces, within a time period of 5 minutes or less swells and/or gels and the texture of the swelled vehicle being similar to that of a soft pudding and having a viscosity of at least about 10,000 cps as measured by a Brookfield Viscometer with a #4 LV spindle at 6 rpm and at 20-25° C. In one embodiment of the invention, the particulate matter can be moulded into a desired shape or pressed onto a dispensing unit such as a spoon. | 12-04-2008 |
Gina Fischer, Værløse DK
| Patent application number | Description | Published |
|---|---|---|
| 20100166866 | MATRIX COMPOSITIONS FOR CONTROLLED DELIVERY OF DRUG SUBSTANCES - A novel matrix composition for pharmaceutical use. The matrix composition has been designed so that it is especially suitable in those situation where an improved bioavailability is desired and/or in those situation where a slightly or insoluble active substance is employed. Accordingly, a controlled release pharmaceutical composition for oral use is provided in the form of a coated matrix composition, the matrix composition comprising i) a mixture of a first and a second polymer that have plasticizing properties and which have melting points or melting intervals of a temperature of at the most 200° C., the first polymer being selected from the group consisting of polyethylene glycols and polyethylene oxides, and the second polymer being selected form block copolymer of ethylene oxide and propylene oxide including poly(ethylene-glycol-b-(DL-lactic acid-co-glycolic acid)-b-ethylene glycol (PEG-PLGA PEG), poly((DL-lactic acid-co-glycolic acid)-g-ethylene glycol) (PLGA-g-PEG), poloxamers and polyethylene oxide-polypropylene oxide (PEO-PPO), ii) a therapeutically, prophylactically and/or diagnostically active substance, the matrix composition being provided with a coating having at least one opening exposing at one surface of said matrix, wherein the active substance is released with a substantially zero order release. | 07-01-2010 |
Jana Fischer, Brabrand DK
| Patent application number | Description | Published |
|---|---|---|
| 20100284985 | Composition - The present invention provides a composition comprising (a) an antimicrobial compound of the formula (I) wherein R | 11-11-2010 |
Morten Fischer, Vedbaek DK
| Patent application number | Description | Published |
|---|---|---|
| 20080286415 | Proteases - Proteases derived from | 11-20-2008 |
| 20110158976 | Enzymes for pharmaceutical use - The pharmaceutical use of proteases related to a protease derived from | 06-30-2011 |
Morten Fischer, Copenhagen DK
| Patent application number | Description | Published |
|---|---|---|
| 20100040595 | XYLANSES FOR ANIMAL FEED - The present invention relates to the use in animal feed of a xylanase having a percentage of identity to a | 02-18-2010 |
Morten Fischer, Copenhagen V DK
| Patent application number | Description | Published |
|---|---|---|
| 20090324571 | USE OF BACTERIAL AMYLASES IN FEED FOR BOVINE ANIMALS - The invention relates to the use of at least one bacterial amylase in feed for ruminant animals of the subfamily Bovinae in particular for improving milk yield, apparent digestibility of the diet fed, feedstuff dry matter disappearance, weight gain, and/or Feed Conversion Ratio (FCR). Examples of bovine animals are dairy cows and beef cattle. The invention also relates to the use of such amylases in feed and feed additives such as premix, concentrates and total mixed ration (TMR). The amylase may be used in combination with cellulase for improving milk yield and/or back fat thickness. Preferred amylases are derived from | 12-31-2009 |
Torsten Fischer, Ringkobing DK
| Patent application number | Description | Published |
|---|---|---|
| 20110006538 | MONOPILE FOUNDATION FOR OFFSHORE WIND TURBINE - The invention relates to methods for installing a wind turbine. A method may comprise the steps of establishing a substructure, said substructure comprising at least one pipe ( | 01-13-2011 |